Stock Events

Stock Events

Check-Cap

€0

0

+€0+0% Today

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 7CC.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Exact Sciences offers Cologuard, a non-invasive colon cancer screening test, directly competing with Check-Cap's capsule-based screening technology.

Intuitive Surgical

Intuitive Surgical specializes in robotic-assisted surgery, offering an alternative to Check-Cap's non-invasive approach by providing minimally invasive surgical options.

Medtronic offers a broad range of medical devices that include gastrointestinal and endoscopic products, competing with Check-Cap in the broader market for diagnostic solutions.

Boston Scientific

Boston Scientific produces endoscopy equipment and devices, offering competitive technologies for diagnosing and managing gastrointestinal conditions.

Guardant Health

Guardant Health offers liquid biopsy tests for cancer detection, providing a non-invasive alternative to traditional and emerging diagnostic methods, including Check-Cap's.

NovoCure develops treatment for cancer using Tumor Treating Fields, a different approach but competes for the same oncology market as Check-Cap's diagnostic solutions.

Stryker specializes in medical technologies, including endoscopic and surgical devices, competing in the broader market for medical devices that can be used in diagnosis and treatment of gastrointestinal diseases.

About

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Show more...

CEO

Mr. David Lontini

Employees

85

Country

United States

ISIN

IL0011336851

Listings

0 Comments

Share your thoughts

FAQ

What is Check-Cap stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Check-Cap stocks are traded under the ticker 7CC.MU.

How many employees does Check-Cap have?▼

As of April 12, 2026, the company has 85 employees.

In which sector is Check-Cap located?▼

Check-Cap operates in the Health & Wellness sector.

When did Check-Cap complete a stock split?▼

Check-Cap has not had any recent stock splits.

Where is Check-Cap headquartered?▼

Check-Cap is headquartered in Isfiya, United States.